Companies: 10,795·Total market cap: $144.5T
LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock

LBRXNASDAQHealthcare● Active
$29.40
+$0.87(+3.05%)
Market Cap$843093569
P/E Ratio
52W High$33.47
52W Low$13.36
Overview

LB Pharmaceuticals Inc Common Stock (LBRX) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · LBRX · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-12
Operating Activities
Net Income($0.03B)($0.06B)($0.01B)($0.01B)
Depreciation & Amort.$0.00B$0.00B$0.00B$0.00B
Stock-Based Comp.$0.00B$0.00B$0.00B$0.00B
Change in Working Capital($0.01B)$0.00B($0.00B)$0.00B
Net Cash from Operations($0.04B)($0.05B)($0.01B)($0.00B)
Investing Activities
Capital Expenditure($0.00B)($0.00B)($0.00B)$0.00B
Purchases of Investments($0.04B)($0.03B)($0.03B)$0.00B
Sales of Investments$0.01B$0.05B$0.01B$0.00B
Net Cash from Investing($0.04B)$0.02B($0.03B)$0.00B
Financing Activities
Common Stock Repurchased$0.00B$0.00B$0.00B$0.00B
Dividends Paid$0.00B$0.00B$0.00B$0.00B
Debt Issued / Repaid$0.00B$0.00B$0.00B$0.03B
Net Cash from Financing$0.30B$0.04B$0.03B$0.02B
Free Cash Flow
Free Cash Flow($0.04B)($0.05B)($0.01B)($0.00B)
FCF Margin %(computed)

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B

Explore more LB Pharmaceuticals Inc Common Stock data

About LB Pharmaceuticals Inc Common Stock (LBRX) Cash Flow Statement

LB Pharmaceuticals Inc Common Stock generated operating cash flow of ($0.04B) and free cash flow of ($0.04B) for 2025 — a FCF margin of —. Capital expenditure was ($0.00B).

Frequently asked questions

LBRX · 4 questions

LB Pharmaceuticals Inc Common Stock generated free cash flow of ($0.04B) for 2025, up 34.5% year-over-year.

LBRX free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10